<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04268459</url>
  </required_header>
  <id_info>
    <org_study_id>1WF_CT_1_2020</org_study_id>
    <nct_id>NCT04268459</nct_id>
  </id_info>
  <brief_title>Estimation of Benefit From Regular Versus Leakage-related Exchange of Voice Prosthesis in Patients Post Laryngectomy.</brief_title>
  <acronym>RvLPE</acronym>
  <official_title>Estimation of Benefit From Regular Versus Leakage-related Exchange of Voice Prosthesis in Patients Post Laryngectomy Considering Complications Rate, Fistula Colonization by Candida Species and Patients Satisfaction Feedback.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The tracheoesophageal voice with voice prosthesis is currently the mainstay of voice
      rehabilitation post laryngectomy. The primary surgical technique of tracheoesophageal fistula
      formation with insertion of prosthesis and quick and easy process of voice rehabilitation are
      main encouraging factors. However, the usage of the prosthesis relates to a significant
      number of complications rated from 10 to 60%. The most common reported complication is
      transprosthetic leakage that determines the need of device exchange. However in some patients
      occur more serious complications eg. periprosthetic leakage, granulation or atrophy of mucosa
      around the fistula, dislocation of prosthesis, that may require anti-inflammatory treatment,
      temporary nasogastric tube feeding or surgical procedure. The standard protocol is voice
      prosthesis exchange due to transprosthetic leakage. Optionally the device could be replaced
      regularly to prevent both transprosthetic leakage and other complication occurrence.

      In the study we plan to compare the benefits from regular (each three month) versus
      leakage-related exchange of voice prosthesis post laryngectomy including the rate of
      complications, fistula colonization by Candida species and patients feedback.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 10, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of complications rate.</measure>
    <time_frame>Control will be continued for 12 months post laryngectomy.</time_frame>
    <description>In both arms of the study we will compare the incidence of following complications: periprosthetic leakage, granulation or atrophy of mucosa around the fistula, dislocation of prosthesis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fistula colonization with Candida species.</measure>
    <time_frame>Control will be continued for 12 months post laryngectomy.</time_frame>
    <description>We will compare microbiological results on subsequent prosthesis exchanges in both arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthesis replacement scheme and patient satisfaction.</measure>
    <time_frame>Control will be continued for 12 months post laryngectomy.</time_frame>
    <description>On each voice prosthesis exchange patients will be asked three questions, assessed with Visual Analog Scale, on their feedback on voice prosthesis use, procedure of prosthesis replacement and voice quality.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Laryngectomy</condition>
  <condition>Voice</condition>
  <condition>Prosthesis Failure</condition>
  <arm_group>
    <arm_group_label>Regular exchange</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be appointed each 3 months for regular exchange of voice prosthesis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Leakage exchange</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will have voice prosthesis exchange when leakage occurs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Provox prosthesis exchange</intervention_name>
    <description>Each patient post laryngectomy will be randomly assigned to one arm of intervention. The voice prosthesis exchange in all patients will be performed in local anaesthesia. The microbiological samples with cotton swabs will be collected from tracheoesophageal fistula on prosthesis exchange. The clinical evaluation and patients satisfaction from prosthesis usage will be performed on each exchange.</description>
    <arm_group_label>Leakage exchange</arm_group_label>
    <arm_group_label>Regular exchange</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients post laryngectomy with primary insertion of voice prosthesis

        Exclusion Criteria:

          -  patients post laryngopharyngectomy with digestive tract reconstruction with jejunum of
             free flap
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Rzepakowska, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Rzepakowska, PhD</last_name>
    <phone>+48225992521</phone>
    <email>arzepakowska@wum.edu.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel Majszyk, PhD</last_name>
    <phone>+48225992521</phone>
    <email>daniel.majszyk@wum.edu.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Otorhinolaryngology, Head andNeck Surgery of Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <last_name>Anna Rzepakowska, PhD</last_name>
      <phone>+48225992521</phone>
      <email>arzepakowska@wum.edu.pl</email>
    </contact>
    <contact_backup>
      <last_name>Ewa Osuch-WÃ³jcikiewicz, Professor</last_name>
      <phone>+48225992521</phone>
      <email>eosuch@wum.edu.pl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 10, 2020</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Anna Rzepakowska</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>voice prosthesis, laryngectomy, complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prosthesis Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Date will become available from April 2022 until April 2023.</ipd_time_frame>
    <ipd_access_criteria>on request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

